Hypertriglyceridemia News

Isis Initiates Phase 2 Study of ISIS-APOCIIIRx in Patients with ... - MarketWatch (press release)



Isis Initiates Phase 2 Study of ISIS-APOCIIIRx in Patients with ... 
MarketWatch (press release)
Hypertriglyceridemia, a condition characterized by high levels of triglycerides, is often associated with premature coronary artery disease and pancreatitis. Patients with severe hypertriglyceridemia often cannot control their triglyceride levels with ...
Isis Pharmaceuticals' CEO Discusses Clinical Development Plans for ISIS ... Seeking Alpha
Phase I trial of novel HER2/neu Antigens will Start at Mayo; Isis Initiates ... BioMedReports (subscription)

all 13 news articles » 


Isis begins Phase II hypertriglyceridemia study with ISIS-APOCIIIRx - Pharmaceutical Business Review



Isis begins Phase II hypertriglyceridemia study with ISIS-APOCIIIRx 
Pharmaceutical Business Review
Isis Pharmaceuticals has begun the Phase II study evaluating the safety and efficacy of ISIS-APOCIIIRx in patients with very high triglycerides. The randomized, placebo-controlled study, which will enroll approximately 100 patients who have ...
Isis Initiates Phase 2 Study of ISIS-APOCIIIRx in Patients with ... Benzinga

all 2 news articles » 


The Benefit of Low Fat Pet Food in Dogs with GI Disease - VetPracticeNews.com



VetPracticeNews.com 
The Benefit of Low Fat Pet Food in Dogs with GI Disease 
VetPracticeNews.com
One indication for low-fat dietary intake in dogs with gastrointestinal disease is the management of dogs with hypertriglyceridemia with GI disease presumed to be due to or related to hypertriglyceridemia. The second indication is a group of dogs that ...

 


Omthera Pharmaceuticals Announces Positive Top-Line Results from Phase 3 ... - MarketWatch (press release)



Omthera Pharmaceuticals Announces Positive Top-Line Results from Phase 3 ... 
MarketWatch (press release)
Hypertriglyceridemia refers to a condition in which patients have high blood levels of triglycerides and is associated with increased risk of heart disease. It is one component of a range of lipid disorders collectively referred to as dyslipidemia.

and more » 


Omthera Pharmaceuticals Announces Positive Top-Line Results from Phase 3 ... - PR Newswire (press release)



Omthera Pharmaceuticals Announces Positive Top-Line Results from Phase 3 ... 
PR Newswire (press release)
Hypertriglyceridemia refers to a condition in which patients have high blood levels of triglycerides and is associated with increased risk of heart disease. It is one component of a range of lipid disorders collectively referred to as dyslipidemia.

and more » 


Pfizer Provides Topline Results From Phase 3 Study Of Torisel(R) As Second ... - MarketWatch (press release)



Pfizer Provides Topline Results From Phase 3 Study Of Torisel(R) As Second ... 
MarketWatch (press release)
The most common laboratory abnormalities (incidence greater-than or equal to 30%) are anemia (94%), hyperglycemia (89%), hyperlipemia (87%), hypertriglyceridemia (83%), elevated alkaline phosphatase (68%), elevated serum creatinine (57%), ...
Pfizer Provides Topline Results From Phase 3 Study Of Torisel® As Second-Line ... EON: Enhanced Online News (press release)

all 23 news articles » 


Researchers Looking for Drug Candidates Tap into the Final Frontier: The Sea - Genetic Engineering News



Researchers Looking for Drug Candidates Tap into the Final Frontier: The Sea 
Genetic Engineering News
To date, there are nine therapeutic agents (six anticancer, one antiviral, one for pain control, and one for hypertriglyceridemia) that derive from the marine environment, according to William H. Gerwick, Ph.D., of Scripps Institution of Oceanography ...

and more » 


Santarus' CEO Presents at Bank of America Merrill Lynch 2012 Health Care ... - Seeking Alpha



Santarus' CEO Presents at Bank of America Merrill Lynch 2012 Health Care ... 
Seeking Alpha
This is of course fenofibrate, it's a low dose version of fenofibrate and of course indicated for the treatment of hypertriglyceridemia as well as mixed dyslipidemia. And you are well aware, the high overlap of co-morbidity and obesity and ...

and more » 


Amylin Pharmaceuticals Reports First Quarter 2012 Financial Results - MarketWatch (press release)



Amylin Pharmaceuticals Reports First Quarter 2012 Financial Results 
MarketWatch (press release)
In addition, we recently completed the Biologics License Application submission to the FDA for the use of metreleptin to treat diabetes and/or hypertriglyceridemia in pediatric and adult patients with rare forms of lipodystrophy and are excited to ...

and more » 


Canaccord Genuity Reiterates a 'Buy' on Amarin Corporation (AMRN); Next Stop ... - StreetInsider.com (subscription)



Canaccord Genuity Reiterates a 'Buy' on Amarin Corporation (AMRN); Next Stop ... 
StreetInsider.com (subscription)
We think AMR101, Amarin's 96% EPA omega-3 for high triglycerides, will be approved for hypertriglyceridemia in H2/12, likely around its July 26 PDUFA data, with a broad label that will include ANCHOR trial mixed dyslipidemia data.

and more »